ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 147 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,277,734 | -18.7% | 2,214,685 | -11.5% | 0.00% | – |
| Q2 2023 | $4,029,467 | -52.9% | 2,502,775 | -15.1% | 0.00% | -100.0% |
| Q1 2023 | $8,546,984 | -3.1% | 2,947,236 | +9.6% | 0.00% | 0.0% |
| Q4 2022 | $8,822,361 | -20.8% | 2,689,744 | -8.8% | 0.00% | -50.0% |
| Q3 2022 | $11,146,000 | -55.6% | 2,948,916 | -8.5% | 0.00% | -33.3% |
| Q2 2022 | $25,114,000 | -11.1% | 3,223,884 | +6.1% | 0.00% | -25.0% |
| Q1 2022 | $28,236,000 | -29.5% | 3,039,516 | +19.5% | 0.00% | -20.0% |
| Q4 2021 | $40,079,000 | -20.3% | 2,543,048 | -9.5% | 0.01% | -28.6% |
| Q3 2021 | $50,295,000 | +6.5% | 2,809,760 | -7.4% | 0.01% | +16.7% |
| Q2 2021 | $47,205,000 | +3.3% | 3,035,747 | -4.6% | 0.01% | -14.3% |
| Q1 2021 | $45,703,000 | -35.8% | 3,182,716 | -12.2% | 0.01% | -36.4% |
| Q4 2020 | $71,158,000 | +319.1% | 3,624,950 | +176.7% | 0.01% | +266.7% |
| Q3 2020 | $16,977,000 | +49.9% | 1,309,945 | +68.5% | 0.00% | 0.0% |
| Q2 2020 | $11,329,000 | -61.5% | 777,527 | -77.5% | 0.00% | -62.5% |
| Q1 2020 | $29,463,000 | -39.0% | 3,462,329 | +18.1% | 0.01% | -27.3% |
| Q4 2019 | $48,304,000 | +15.8% | 2,932,847 | -0.7% | 0.01% | 0.0% |
| Q3 2019 | $41,703,000 | +3.8% | 2,953,605 | +47.9% | 0.01% | 0.0% |
| Q2 2019 | $40,171,000 | -21.2% | 1,997,538 | +55.8% | 0.01% | -21.4% |
| Q1 2019 | $50,978,000 | -19.8% | 1,282,461 | -29.9% | 0.01% | -26.3% |
| Q4 2018 | $63,596,000 | -18.6% | 1,830,647 | -3.1% | 0.02% | -5.0% |
| Q3 2018 | $78,157,000 | +4.2% | 1,890,131 | -7.4% | 0.02% | 0.0% |
| Q2 2018 | $75,042,000 | -10.9% | 2,041,951 | -5.4% | 0.02% | -13.0% |
| Q1 2018 | $84,195,000 | +167.8% | 2,158,870 | +24.3% | 0.02% | +155.6% |
| Q4 2017 | $31,436,000 | +32.1% | 1,736,804 | +20.8% | 0.01% | +28.6% |
| Q3 2017 | $23,792,000 | +72.3% | 1,437,661 | +45.7% | 0.01% | +75.0% |
| Q2 2017 | $13,812,000 | +92.0% | 986,547 | +181.8% | 0.00% | +300.0% |
| Q1 2017 | $7,194,000 | +258.3% | 350,116 | +147.6% | 0.00% | – |
| Q4 2016 | $2,008,000 | +1124.4% | 141,378 | +1742.8% | 0.00% | – |
| Q3 2016 | $164,000 | +92.9% | 7,672 | +102.9% | 0.00% | – |
| Q2 2016 | $85,000 | -24.1% | 3,781 | -36.0% | 0.00% | – |
| Q1 2016 | $112,000 | -96.6% | 5,905 | -95.3% | 0.00% | -100.0% |
| Q4 2015 | $3,326,000 | +447.0% | 125,960 | +551.5% | 0.00% | – |
| Q3 2015 | $608,000 | +91.2% | 19,334 | +221.3% | 0.00% | – |
| Q2 2015 | $318,000 | +7850.0% | 6,017 | +6585.6% | 0.00% | – |
| Q1 2015 | $4,000 | -80.0% | 90 | -88.2% | 0.00% | – |
| Q4 2014 | $20,000 | – | 764 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,576,000 | 23.33% |
| Antipodean Advisors LLC | 1,000,000 | $15,760,000 | 6.47% |
| M28 Capital Management LP | 456,865 | $7,200,000 | 5.62% |
| Redmile Group, LLC | 6,437,777 | $101,459,000 | 2.31% |
| One Fin Capital Management LP | 303,000 | $4,775,000 | 1.99% |
| MAVERICK CAPITAL LTD | 7,855,824 | $123,808,000 | 1.40% |
| Baupost Group | 8,477,488 | $133,605,000 | 1.32% |
| BRIDGER MANAGEMENT, LLC | 616,488 | $9,716,000 | 1.26% |
| 683 Capital Management, LLC | 1,781,234 | $28,073,000 | 1.03% |
| Trellus Management Company, LLC | 95,000 | $1,497,000 | 1.00% |